Patricia Krief

786 total citations
31 papers, 575 citations indexed

About

Patricia Krief is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Patricia Krief has authored 31 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 9 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Patricia Krief's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Patricia Krief is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Patricia Krief collaborates with scholars based in France, United Kingdom and United States. Patricia Krief's co-authors include Christian Boîtard, Jacques Jami, Bruno Azzarone, Philippe Halbout, Jean‐Claude Carel, Jean‐Paul Briand, Sylviane Muller, Véronique Laloux, Agnès Lehuen and Joëlle Morin and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Patricia Krief

30 papers receiving 565 citations

Peers

Patricia Krief

GENET

IMMUN

SURGE

EDM

MB

Juha Ollila Finland

S S Boggs United States

S I Taylor United States

Eyal Fima Israel

Toshiyuki Mera Japan

Kathryn A. Tunny Australia

Laura Alcalde Spain

Taishi Sasaoka Japan

H Stobbe Germany

C.B.J.M. Cleutjens Netherlands

Juha Ollila Finland

Patricia Krief

238 ×0.9

GENET

226 ×0.9

IMMUN

32 ×0.2

SURGE

214 ×1.5

EDM

416 ×3.5

MB

Citations per year, relative to Patricia Krief Patricia Krief (= 1×) peers Juha Ollila

Countries citing papers authored by Patricia Krief

Since Specialization

Citations

This map shows the geographic impact of Patricia Krief's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Krief with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Krief more than expected).

Fields of papers citing papers by Patricia Krief

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Krief. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Krief. The network helps show where Patricia Krief may publish in the future.

Co-authorship network of co-authors of Patricia Krief

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Krief. A scholar is included among the top collaborators of Patricia Krief based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Krief. Patricia Krief is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Padua, Rose Ann, Satyananda Patel, James S. Smith, et al.. (2024). Immunotherapy with pVAX14 Nucleic Acid in Combination with All-Trans Retinoic Acid (ATRA) in an Acute Promyelocytic Leukemia (APL) Mouse Model Activates Cytotoxic T-Cells and Enhances Immune Responses: A Strategy for Turning “Cold” Tumors “Hot”. Blood. 144(Supplement 1). 4292–4292. 1 indexed citations

2.

Padua, Rose Ann, Laure Sarda‐Mantel, Patricia Krief, et al.. (2018). BCL-2 Inhibitor Venetoclax (ABT-199) and MEK Inhibitor GDC-0973 Synergise to Target AML Progenitors and Overcome Drug Resistance with the Use of PET Scanning in a Mouse Model of HR-MDS to Monitor Response to Treatment. Blood. 132(Supplement 1). 5497–5497. 6 indexed citations

3.

Beurlet, Stéphanie, M.S. Said, Fabien Guidez, et al.. (2016). GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways. Journal of Hematology & Oncology. 9(1). 5–5. 6 indexed citations

4.

Beurlet, Stéphanie, Patricia Krief, Jean‐Jacques Kiladjian, et al.. (2011). Identification of JAK2 mutations in canine primary polycythemia. Experimental Hematology. 39(5). 542–545. 13 indexed citations

5.

Pokorná, Kateřina, Murielle Reboul, Véronique Bajzik, et al.. (2009). DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model. Blood. 115(3). 653–656. 20 indexed citations

6.

Auffray, Cédric, Régis Gayon, Abdellatif Benraiss, et al.. (2005). An 8-bp deletion in mNOTCH4 intron 10 leads to its retention in mRNA and to synthesis of a truncated protein. Experimental Cell Research. 312(3). 233–44. 6 indexed citations

7.

Briand, Jean‐Paul, Chantal Lotton, Isabelle Tardivel, et al.. (2004). Expression of Preproinsulin-2 Gene Shapes the Immune Response to Preproinsulin in Normal Mice. The Journal of Immunology. 172(1). 25–33. 22 indexed citations

8.

Krief, Patricia, Jean‐Paul Briand, Philippe Halbout, et al.. (2003). Acceleration of type 1 diabetes mellitus in proinsulin 2–deficient NOD mice. Journal of Clinical Investigation. 111(6). 851–857. 185 indexed citations

9.

Krief, Patricia, Jean‐Paul Briand, Philippe Halbout, et al.. (2003). Acceleration of type 1 diabetes mellitus in proinsulin 2–deficient NOD mice. Journal of Clinical Investigation. 111(6). 851–857. 21 indexed citations

10.

Jami, Jacques, et al.. (2002). Proinsulin 2 Knockout NOD Mice. Diabetes. 51(suppl_3). S489–S493. 17 indexed citations

11.

Lévesque, Jean-Pierre, et al.. (1998). Mitogenic Effect of Fibrinogen on Hematopoietic Cells: Involvement of Two Distinct Specific Receptors, MFR and ICAM-1. Biochemical and Biophysical Research Communications. 246(1). 231–237. 2 indexed citations

12.

Assier, Éric, Haniaa Bouzinba-Ségard, Bruno Azzarone, et al.. (1997). Inhibitor (IK) of IFN-γ induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line. Oncogene. 14(12). 1453–1461. 12 indexed citations

13.

Plaisance, Stéphane, et al.. (1992). Expression of the interleukin-2 receptor on human fibroblasts and its biological significance. International Immunology. 4(7). 739–746. 37 indexed citations

14.

Alileche, Abdelkrim, et al.. (1992). Inhibition of human immunodeficiency virus (HIV) type 1 multiplication by an avian cellular factor. Archives of Virology. 123(3-4). 309–321.

15.

Krief, Patricia, Claude Saint‐Ruf, Marc Bracke, et al.. (1989). Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin β3 and increased expression of c‐myc. International Journal of Cancer. 43(4). 658–664. 13 indexed citations

16.

H, Lu, Patricia Krief, Claudine Soria, et al.. (1988). Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells. Biochemical and Biophysical Research Communications. 155(1). 418–422. 32 indexed citations

17.

Azzarone, Bruno, Christine Chaponnier, Patricia Krief, et al.. (1988). Human fibroblasts from cancer patients: lifespan and transformed phenotype in vitro and role of mesenchyme in vivo. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 199(2). 313–325. 12 indexed citations

18.

Leprince, Corinne, Yolande Richard, Patricia Krief, et al.. (1988). A B cell-restricted activation antigen (B8.7) functionally related to the low molecular weight B cell growth factor receptor.. The Journal of Immunology. 140(1). 100–107. 11 indexed citations

19.

Boucheix, Claude, Patricia Krief, Jean‐Yves Perrot, Massoud Mirshahi, & C. Rosenfeld. (1986). [55] Method for rapid detection of membrane antigens by immunofluorescence and its application to screening monoclonal antibodies. Methods in enzymology on CD-ROM/Methods in enzymology. 121. 580–587. 2 indexed citations

20.

Azzarone, Bruno, Patricia Krief, Jeannette Soria, & Claude Boucheix. (1985). Modulation of fibroblast‐induced clot retraction by calcium channel blocking drugs and the monoclonal antibody ALB6. Journal of Cellular Physiology. 125(3). 420–426. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact